Cart
sales@molnova.com
Pomalidomide-PEG4-C2-NH2 hydrochloride
CAS No. 2357105-92-9
Pomalidomide-PEG4-C2-NH2 hydrochloride ( —— )
Catalog No. M28272 CAS No. 2357105-92-9
Pomalidomide-PEG4-C2-NH2 hydrochloride is a PEG-based PROTAC linker that can be used to synthesize PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 46 | Get Quote |
|
| 25MG | 77 | Get Quote |
|
| 50MG | 125 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePomalidomide-PEG4-C2-NH2 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionPomalidomide-PEG4-C2-NH2 hydrochloride is a PEG-based PROTAC linker that can be used to synthesize PROTACs.
-
DescriptionPomalidomide-PEG4-C2-NH2 hydrochloride is a PEG-based PROTAC linker that can be used to synthesize PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorSOS1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2357105-92-9
-
Formula Weight529.0
-
Molecular FormulaC23H33ClN4O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=CC=C3NCCOCCOCCOCCOCCN)=O.[H]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ketcham JM, et al. Design and Discovery of MRTX0902, a Potent, Selective, Brain-Penetrant, and Orally Bioavailable Inhibitor of the SOS1:KRAS Protein-Protein Interaction. J Med Chem. 2022 Jul 28;65(14):9678-9690.
molnova catalog
related products
-
SAR131675（b）
SAR131675 is an effective and specific VEGFR-3 inhibitor. It inhibited VEGFR-3 tyrosine kinase activity (IC50: 20 nmol/L) and VEGFR-3 autophosphorylation (IC50: 45 nmol/L) in HEK cells, respectively.
-
Benzylurea
Benzylurea competitively inhibits dehydrogenase/cytokinin oxidase.
-
ML382
ML382 is a potent and selective MrgX1 positive allosteric modulator(EC50 : 190 nM).ML382 enhances the ability of BAM8-22 to inhibit high-voltage-activated Ca2+ channels and attenuate spinal nociceptive transmission, both BAM8-22 and ML382 effectively attenuated evoked, persistent, and spontaneous pain without causing obvious side effects.?
